[go: up one dir, main page]

PT95697A - Processo para a preparacao de composicoes farmaceuticas contendo substancias antiandrogenicamente activas - Google Patents

Processo para a preparacao de composicoes farmaceuticas contendo substancias antiandrogenicamente activas

Info

Publication number
PT95697A
PT95697A PT95697A PT9569790A PT95697A PT 95697 A PT95697 A PT 95697A PT 95697 A PT95697 A PT 95697A PT 9569790 A PT9569790 A PT 9569790A PT 95697 A PT95697 A PT 95697A
Authority
PT
Portugal
Prior art keywords
andorgenically
preparation
pharmaceutical compositions
compositions containing
active substances
Prior art date
Application number
PT95697A
Other languages
English (en)
Other versions
PT95697B (pt
Inventor
Georg Roessling
Andreas Schase
Jutta Riedl
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of PT95697A publication Critical patent/PT95697A/pt
Publication of PT95697B publication Critical patent/PT95697B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT95697A 1989-10-27 1990-10-26 Processo para a preparacao de composicoes farmaceuticas contendo substancias antiandrogenicamente activas PT95697B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3936328A DE3936328A1 (de) 1989-10-27 1989-10-27 Pharmazeutische praeparate

Publications (2)

Publication Number Publication Date
PT95697A true PT95697A (pt) 1991-09-13
PT95697B PT95697B (pt) 1997-09-30

Family

ID=6392630

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95697A PT95697B (pt) 1989-10-27 1990-10-26 Processo para a preparacao de composicoes farmaceuticas contendo substancias antiandrogenicamente activas

Country Status (15)

Country Link
US (1) US5723146A (pt)
EP (1) EP0451237B1 (pt)
JP (1) JP3011762B2 (pt)
AT (1) ATE103804T1 (pt)
AU (1) AU6553790A (pt)
CA (1) CA2028629C (pt)
DE (2) DE3936328A1 (pt)
DK (1) DK0451237T3 (pt)
FI (1) FI913100A7 (pt)
GR (1) GR900100772A (pt)
HU (1) HU215127B (pt)
IE (1) IE903859A1 (pt)
NO (1) NO912435D0 (pt)
PT (1) PT95697B (pt)
WO (1) WO1991006284A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6733776B1 (en) * 1992-04-02 2004-05-11 Anticancer, Inc. Method for promoting hair growth
US7556825B2 (en) * 1993-04-02 2009-07-07 Anticancer, Inc. Method for promoting hair growth
US6844326B2 (en) * 1995-06-07 2005-01-18 Anticancer, Inc. Treatment of alopecia
DE19916384A1 (de) * 1999-03-31 2000-10-05 Schering Ag Cyproteronacetat, Chlormadinonacetat oder 17alpha-Propylmesterolon enthaltende, bioerosive Mikropartikeln, Verfahren zu deren Herstellung, therapeutische Verwendung dieser in topischen Arzneiformen
JP3466516B2 (ja) 1999-09-07 2003-11-10 科学技術振興事業団 安定保存可能な酸素輸液剤
EP1316317A1 (fr) * 2001-11-30 2003-06-04 University of Liege Associations hydrosolubles à base de cyprotérone et/ou d'un ester de celle-ci, leurs préparations et leurs utilisations
US20030219465A1 (en) * 2002-05-23 2003-11-27 Suresh Kumar Gidwani Composition for delivery of dithranol
EP1643971A2 (en) * 2003-05-22 2006-04-12 Neopharm, Inc. Liposomal formulations comprising a combination of two or more active agents
US20050095283A1 (en) * 2003-09-16 2005-05-05 Aphios Corporation Compositions and methods for topically treating diseases
MX2007002462A (es) * 2004-09-03 2007-10-10 Piedmont Pharmaceuticals Llc Metodo para el tratamiento de transmembrana y prevencion de la otitis media.
AU2006295248A1 (en) * 2005-09-26 2007-04-05 Piedmont Pharmaceuticals Llc Methods for treatment and prevention of otitis media using nonionic surfactants to facilitate transmembrane drug delivery into the middle ear
CN101272772A (zh) * 2005-09-26 2008-09-24 皮埃蒙特医药品有限公司 使用化学渗透促进剂促进跨膜药物输送到中耳治疗和预防中耳炎的方法
DE102006062120A1 (de) 2006-12-22 2008-06-26 Grünenthal GmbH Pharmazeutische Zusammensetzung zur Aknebehandlung
JP5128592B2 (ja) * 2007-05-29 2013-01-23 ポーラ化成工業株式会社 皮膚外用剤に有用なベシクル及び該ベシクルを含有する皮膚外用剤
EA022208B1 (ru) * 2008-10-10 2015-11-30 Тева Вимен'С Хелс, Инк. Способы лечения вазомоторных симптомов у кастрированных пациентов с раком предстательной железы низкими дозами ципротерона ацетата
ITMI20110644A1 (it) * 2011-04-14 2012-10-15 Giuliani Spa Sistema per il rilascio prolungato di agenti cosmetici

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3728364A (en) * 1971-07-27 1973-04-17 Syntex Corp Preparation of 17alpha-propadienyl steroids
GB1570524A (en) * 1976-03-11 1980-07-02 Unilever Ltd Cosmetic
IL64397A0 (en) * 1981-01-07 1982-02-28 Weder Hans G Process for the preparation of liposomal medicaments
US4396615A (en) * 1981-06-24 1983-08-02 Duke University Method of treating androgen-related disorders
DE3279999D1 (en) * 1981-09-30 1989-11-30 Nat Res Dev Compositions comprising encapsulated particles
DE3416978A1 (de) * 1983-05-12 1984-12-06 Stauffer Chemical Co., Westport, Conn. Durch liposom vermittelte transformation eukaryotischer zellen
EP0240630A3 (en) * 1986-04-10 1989-01-25 University Of Miami Treatment of skin of over androgenicity using compositions containing pregnenolone
AU4805085A (en) * 1984-09-05 1986-03-24 Schering Aktiengesellschaft Mittel zur behandlung von androgenisierungserscheinungen und verwendung von antiandrogenen zur herstellung des mittels
IT1199625B (it) * 1985-01-08 1988-12-30 Finchimica Srl Uso terapeutico del ciproterone acetato
FR2619505B1 (fr) * 1987-08-20 1990-08-31 Dior Christian Parfums Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant de la pregnenolone ou un ester de pregnenolone, et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite regeneratrice ou revitalisante, l'incorporant
DE3738620A1 (de) * 1987-11-13 1989-05-24 Luderschmidt Christoph Verwendung von ethisterone zur topischen behandlung von akne oder androgenetischer alopezie
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs

Also Published As

Publication number Publication date
JP3011762B2 (ja) 2000-02-21
IE903859A1 (en) 1991-05-08
WO1991006284A1 (de) 1991-05-16
DE3936328A1 (de) 1991-05-02
FI913100A0 (fi) 1991-06-25
EP0451237A1 (de) 1991-10-16
DE59005281D1 (de) 1994-05-11
US5723146A (en) 1998-03-03
HU215127B (hu) 1998-09-28
AU6553790A (en) 1991-05-02
NO912435L (no) 1991-06-21
HU907959D0 (en) 1991-11-28
CA2028629A1 (en) 1991-04-28
HUT57590A (en) 1991-12-30
DK0451237T3 (da) 1994-07-18
JPH04503676A (ja) 1992-07-02
CA2028629C (en) 2000-12-19
EP0451237B1 (de) 1994-04-06
ATE103804T1 (de) 1994-04-15
NO912435D0 (no) 1991-06-21
PT95697B (pt) 1997-09-30
GR900100772A (el) 1992-03-20
FI913100A7 (fi) 1991-06-25

Similar Documents

Publication Publication Date Title
PT95697A (pt) Processo para a preparacao de composicoes farmaceuticas contendo substancias antiandrogenicamente activas
EE04021B1 (et) 7a-( -aminoalküül)östratrieenid, nende valmistamise meetod, 7a-( -aminoalküül)östratrieene sisaldavad farmatseutilised preparaadid ja nende kasutamine ravimite valmistamiseks
KR880005921A (ko) 의약용 소입자 에어로졸 리포좀 및 의약용 리포좀-약제 조합물
DK634787A (da) Topiske farmaceutiske praeparater til behandling af acne
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
EP0252286A3 (en) Pharmaceutical preparations for topical use, process for their manufacture and their use
PT92120A (pt) Processo para a preparacao de composicoes oftalmologicas contendo ciclosporina
BG96513A (bg) Заместени 4-фенил-4-пиперидинкарбоксамиди с локален обезболяващ и болкоуспокояващ ефект и метод за тяхното получаване
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
IT9067434A0 (it) Procedimento per migliorare l'efficacia terapeutica di corticosteroidi liposolubili e composizione per l'attuazione di tale procedimento
BR9810267A (pt) Preparados de combinações farmacêuticas, processo para a produção dos mesmos, utilização de preparados de eritropoietina e embalagem unitária farmacêutica
BR9302389A (pt) Composto,formulacao farmaceutica e processo para preparar o composto
BR8803182A (pt) 2,5-dihidropirrois,processo para sua preparacao,composicoes herbicidas,processo para o combate a ervas daninhas,aplicacao,processo para a preparacao de composicoes aminoisoxazois e processo para sua preparacoes
FI920425A7 (fi) Sykloalkyleeniatsoleja, menetelmä niiden valmistamiseksi niitä sisältä viä farmaseuttisia valmisteita sekä niiden käyttö lääkeaineiden valmis tamiseen
FI951961L (fi) Tilidiinidivetyortofosfatti, menetelmä sen valmistamiseksi ja sitä sisältäviä farmaseuttisia valmisteita
FI891712A7 (fi) Terapeuttisesti vaikuttavia syklometyleeni-1,2-bikarboksyylihappojen amiineja, menetelmiä niiden valmistamiseksi sekä niitä sisältäviä farmaseuttisia koostumuksia
DK298389D0 (da) Farmaceutisk praeparat til topisk anvendelse omfattende et amin-funktionelt medikament
IT8919637A0 (it) Isomero otticamente attivo della cloperastina avente attivita' antitussiva, processo per la sua preparazione e composizioni farmaceutiche che lo contengono.
IT1184729B (it) Prodotti farmaceutico cosmetico,in particolare per la cura di acne e seborrea
IT8221659A0 (it) Composizione terapeutica adattivita' antibatterica a base di una frazione estratta da fiori di camomilla e processo per lapreparazione di detta frazione.
DE68905076D1 (de) Pharmazeutische zusammensetzung fuer die behandlung von hautwunden.
BR9302809A (pt) Composto,processo para sua preparacao,processo de purificacao dos compostos,medicmanto,emprego e processo para a preparacao de um agente anti-tumoral
PT89531A (pt) Processo para a preparacao de composicoes farmaceuticas contendo ciclofilina e metodo para a sua utilizacao como agente anti-inflamatorio e imunomodulador
HU904062D0 (en) Process for producing substituted 3-amino-sydnonimines and pharmaceutical preparations containing these compounds as active substance
FI950649A7 (fi) Substituoidut sykloheksanoliesterit, niiden käyttö sairauksien hoitamiseksi ja farmaseuttiset valmisteet

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910401

FG3A Patent granted, date of granting

Effective date: 19970627

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20031231